February 8th 2023
By Georgia Hurst
On a recent car ride with my son, I asked him if he planned on being tested for Lynch syndrome, the cancer-related syndrome that I have.
February 8th 2023
By Colleen Moretti
The use of PD-L1 to predict outcomes highlights a possible opportunity to better understand which patients with ER-positive breast cancer may benefit from an immune checkpoint inhibitor.
February 8th 2023
By Khevin Barnes
I don’t think of nature as a distraction to my cancer, masking the symptoms or the reality of my disease, but rather as a therapy that offers comfort and serenity with no negative side effects.
February 8th 2023
By Colleen Moretti
Data suggests an association between tumor DNA circulating in plasma and patient responses to neoadjuvant treatment.
February 8th 2023
By Brielle Benyon
An expert discussed the recent approval of Keytruda for non-small cell lung cancer, and what patients with the disease need to know about the newly approved regimen.
February 8, 2023 10:00 PM
By Georgia Hurst
February 8, 2023 6:00 PM
By Khevin Barnes
February 7, 2023 6:00 PM
By Jane Biehl Ph.D.
February 6, 2023 6:00 PM
By Doris Helene White
January 4, 2023 4:00 PM
December 30, 2022 8:00 PM
December 30, 2022 2:00 PM
December 29, 2022 8:00 PM
February 7, 2023 8:00 PM
By Gina Ross
February 2, 2023 2:00 PM
By Jayanti Chakraborty
January 28, 2023 7:00 PM
By Wendy Reichental
January 26, 2023 2:00 PM
By Stephanie Landon